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Exome Sequencing and cis-Regulatory Mapping
Identify Mutations in MAK, a Gene Encoding a Regulator
of Ciliary Length, as a Cause of Retinitis Pigmentosa
Rıza Ko¨ksal O¨zgu¨l,1,10 Anna M. Siemiatkowska,2,3,10 Didem Yu¨cel,1,10 Connie A. Myers,4
Rob W.J. Collin,2,3,5 Marijke N. Zonneveld,2,3 Avigail Beryozkin,6 Eyal Banin,6 Carel B. Hoyng,5
L. Ingeborgh van den Born,7 The European Retinal Disease Consortium,9 Ron Bose,8 Wei Shen,8
Dror Sharon,6 Frans P.M. Cremers,2,3 B. Jeroen Klevering,5 Anneke I. den Hollander,2,3,5,*
and Joseph C. Corbo4,*
A fundamental challenge in analyzing exome-sequence data is distinguishing pathogenic mutations from background polymorphisms.
To address this problem in the context of a genetically heterogeneous disease, retinitis pigmentosa (RP), we devised a candidate-gene
prioritization strategy called cis-regulatory mapping that utilizes ChIP-seq data for the photoreceptor transcription factor CRX to
rank candidate genes. Exome sequencing combined with this approach identified a homozygous nonsense mutation in male germ
cell-associated kinase (MAK) in the single affected member of a consanguineous Turkish family with RP.MAK encodes a cilium-associated
mitogen-activated protein kinase whose function is conserved from the ciliated alga, Chlamydomonas reinhardtii, to humans. Mutations
in MAK orthologs in mice and other model organisms result in abnormally long cilia and, in mice, rapid photoreceptor degeneration.
Subsequent sequence analyses of additional individuals with RP identified five probands with missense mutations inMAK. Two of these
mutations alter amino acids that are conserved in all known kinases, and an in vitro kinase assay indicates that these mutations result in
a loss of kinase activity. Thus, kinase activity appears to be critical for MAK function in humans. This study highlights a previously
underappreciated role for CRX as a direct transcriptional regulator of ciliary genes in photoreceptors. In addition, it demonstrates the
effectiveness of CRX-based cis-regulatory mapping in prioritizing candidate genes from exome data and suggests that this strategy
should be generally applicable to a range of retinal diseases.Introduction
Next-generation sequencing is currently revolutionizing
Mendelian disease analysis.1 It is now possible to identify
causative mutations in Mendelian disorders via whole-
genome exon (exome) sequencing of affected individ-
uals.2–5 Yet, given that every human genome contains
thousands of codon-altering sequence variants, the funda-
mental challenge in analyzing exome data is identifying
the causal mutation amidst a sea of benign polymor-
phisms.1 A first step in sifting through exome-sequence
variants is removing those that represent known polymor-
phisms in the human population. If a disease is thought to
be genetically homogeneous, the candidate list can then
be further reduced by intersecting exome-sequencing data
from multiple affected individuals and different families.
In diseases that are genetically heterogeneous, however,
this latter filter cannot be applied, and thus there is a need
for additional approaches to candidate-gene prioritization.
Retinal degenerations (RD) represent a genetically
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causing mutation in these individuals is a prerequisite for
proper genetic counseling and for the selection of subjects
for novel gene-specific therapies. Mutations in over 200
genes have been implicated in RD, and this makes it one
of the most genetically heterogeneous families of disease
(see RetNet under Web Resources). Despite this growing
knowledge base, sequencing of genes known to bemutated
in RD locates the causative mutation in only about half of
all individuals with RD.7 Thus, there is a pressing need
for new approaches that will accelerate the discovery of
additional genes involved in this disease.
Here, we present a general approach to prioritizing
retinal-disease gene candidates; we call this approach
‘‘cis-regulatory mapping.’’ The strategy is based on the
findings of a recent study in which we used chromatin
immunoprecipitation followed by massively parallel
sequencing (ChIP-seq) to identify binding sites for the
transcription factor CRX (MIM 602225) across the mouse
genome.9 CRX is a key photoreceptor transcription factor
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including the majority of genes known to be mutated in
RD.10–13 CRX directly regulates photoreceptor genes by
binding to ~10,000 cis-regulatory regions referred to as
CRX-bound regions (CBRs).9 Because the majority of genes
involved in RD are preferentially expressed in photorecep-
tors,9,11,14 we reasoned that clustering of CBRs could be
used to pinpoint genes with mutations causing RD within
lists of candidate genes.
We applied the combined strategy of exome
sequencing and prioritization of candidate genes by
CBR clustering to a Turkish subject with retinitis pigmen-
tosa (RP) who is the only affected member of a consan-
guineous family. This analysis resulted in the identifica-
tion of a homozygous nonsense mutation in male germ
cell-associated kinase (MAK; MIM 154235). We subse-
quently screened Dutch and Israeli subjects with RP
and found five additional missense mutations affecting
critical residues of this protein. MAK encodes a highly-
conserved mitogen-activated protein (MAP) kinase that
regulates ciliary length in a wide range of species.15–17
In addition, it has recently been shown that Mak
mutations in mice cause rapid photoreceptor degenera-
tion.17 This study demonstrates the utility of CRX-based
cis-regulatory mapping as an approach for prioritizing
candidate genes from whole-exome data in individuals
with RD.Subjects and Methods
cis-Regulatory Mapping
CRX ChIP-seq data were generated from 8-week-old mouse retinas
as previously described.9 We used the UCSC Genome Browser
liftover tool to map mouse CBRs onto the human genome.18
CBRs were then assigned to individual genes as previously
described.9 CBRs were assigned to a total of 21,515 and 21,912
RefSeq genes in humans andmice, respectively (Table S1, available
online). This same procedure was repeated for CRX ChIP-seq
data generated from 8-week-old Nrl/ mouse retinas.9 Lists of
candidate genes derived from defined genomic regions or
exome-sequencing datasets were numerically ranked according
to their raw read counts as given in Table S1.Families and DNA Extraction
The tenets of the Declaration of Helsinki were followed, and
informed consent was obtained prior to donation of a blood
sample from all individuals who participated in this study. Blood
samples for DNA analysis were obtained from affected and
unaffected family members. Genomic DNA was extracted from
peripheral blood samples with the FlexiGene DNA kit (Qiagen,
Venlo, the Netherlands) or with a standard salting-out proce-
dure.19 The ethical review boards of Radboud University Nijmegen
Medical Centre, Hacettepe University, and Hadassah-Hebrew
University Medical Center approved this study.Clinical Evaluation
Ophthalmic examinations, including electroretinography (ERG)
according to International Society for Clinical Electrophysiology
of Vision (ISCEV) standards and fundus photography, were254 The American Journal of Human Genetics 89, 253–264, August 1performed for all affected individuals. Goldmann perimetry was
performed in seven of the eight affected individuals.
Exome Sequencing and Analysis
Five micrograms of high-quality genomic DNA from subject
RP-2011 was prepared for sequencing with an Illumina Paired-
End Sample Preparation kit (Illumina Inc., San Diego, CA, USA)
according to manufacturer’s instructions. Coding exons were
captured from the resultant sample with the Agilent SureSelect
Human All Exon kit (Agilent Technologies, Santa Clara, CA,
USA) according to manufacturer’s instructions. Cluster generation
was performed with the Paired-End Cluster Generation kit (v2)
and the Illumina Cluster Station. A paired-end, 75 bp run was
performed on an Illumina Genome Analyzer IIx. Images were
analyzed with the standard Illumina Pipeline (version 1.4), and
a total of 4.5 billion bases of sequence were obtained. Sequences
were aligned with the human genome reference sequence (build
hg18), and variant calls were made and annotated according to
the dbSNP database (build 129). A total of 52 putative homozy-
gous nucleotide changes not present in the dbSNP database were
identified in 38 genes (Table S2). These genes were ranked accord-
ing to CRX-binding scores, and the top five candidate genes were
further evaluated by direct sequence analysis.
Homozygosity Mapping and Mutation Analysis
Whole-genome SNP analysis was performed on subject RP-2011,
her parents, and her siblings with the Affymetrix GeneChip
Mapping 250K array set (Affymetrix, Santa Clara, CA, USA).
Homozygous regions were calculated with Affymetrix GTYPE
software and the VIGENOS (Visual Genome Studio) Program
(Hemosoft Inc., Ankara, Turkey). In addition, whole-genome
SNP analysis was performed on 334 subjects of Dutch, Italian,
Israeli, and Palestinian origin with the Illumina 6K or the Affy-
metrix 10K, 250K, 5.0, or 6.0 SNP arrays (SNP analysis of Dutch
subjects was reported previously20). Homozygous regions were
calculated with Partek software (Partek Incorporated, St. Louis,
MO, USA) or PLINK software.21
Primers for PCR amplification of the 15 exons and exon-intron
boundaries of MAK (including the retina-enriched alternative
exon 13) were designed with Primer 3 software (Table S3). PCR
was performed with 50 ng of genomic DNA in 25 ml reactions
for 35 cycles. PCR fragments were purified with 96-well PCR filter
plates (Millipore, Billerica, MA, USA), and mutation analysis was
performed by direct sequencing of purified PCR products.
Animal Studies
Adult CD1 mice were housed at Washington University in
St. Louis (St. Louis, MO, USA), in an air-conditioned environment
on a 12 hr light-dark cycle at 22C and had free access to water and
food. All animal studies were conducted in accordance with the
Guide for the Care and Use of Laboratory Animals and the Animal
Welfare Act and were approved by the Washington University in
St. Louis institutional animal care and use committee (approval
number 20110089).
CBR-Reporter Fusion Constructs
Three CBRs identified around the MAK locus were obtained
by PCR from human genomic DNA with the primer pairs in-
dicated in Table S3. The resultant PCR products were cloned
into the Rho-basal DsRed reporter vector with the restriction
enzyme sites underlined in the primer (Table S3).13 Retinal2, 2011
electroporation and explant cultures were performed exactly as
described previously.13MAK Expression Constructs
Human retinal cDNAwas generated from total human retinal RNA
with SuperScript II reverse transcriptase (Invitrogen, Carlsbad, CA,
USA) per the manufacturer’s instructions. The retinal isoform of
MAK was generated by PCR with primers shown in Table S3.
A Kozak consensus site (upper case letters in Table S3) was added
to the 50 primer. The resultant PCR product was digested with SacII
and NotI, (underlined in primers in Table S3) and cloned into an
intermediate cloning vector. We determined by sequencing that
the clone was free of mutations and contained the retina-enriched
exon 13.MAKmutations were generated by site directedmutagen-
esis with the Quik-Change II kit (Stratagene, Cedar Creek, TX,
USA) according to the manufacturer’s instructions. Wild-type
and mutant forms of the MAK expression construct were then
cloned in frame with the C-terminal Myc/his tag in
pcDNA3.1(þ)Myc/his A vector (Invitrogen).In Vitro Kinase Assay
MAK-WT-Myc/his, MAK-mut-Myc/his, or empty vector was trans-
fected into HEK293 (PlatE) cells with TransIT-LT1 transfection
reagent (Mirus Bio LLC, Madison, WI, USA). Forty-eight hours
after transfection the cells were washed twice with cold PBS and
lysed on plate in modified RIPA buffer (150 mM NaCl, 50 mM
Tris [pH 7.4], 1% NP-40, 0.25% Sodium Deoxycholate, 1 mM
EDTA). Expression of MAK was confirmed via immunoblot
analysis with 40 mg of total protein from the immunoprecipitation
input lysate. Proteins were run on a 4-12% Bis-Tris gel (Invitrogen)
and transferred to a Protran nitrocellulose membrane (Sigma,
St. Louis, MO). The membranes were blocked for 1 hour at
room temperature with 5% nonfat dry milk in TBST (Tris-buffered
saline with 0.1% Tween 20), incubated with 1:500 dilution of
mouse monoclonal c-Myc (9E10) (Santa Cruz Biotechnology,
Santa Cruz, CA) in TBST with 5% nonfat dry milk followed by
1:5000 dilution of ImmunoPure Goat anti-Mouse HRP (Thermo
Scientific Pierce Protein Research Products, Rockford, IL) and
signal was detected on Classic Blue autoradiography film (Molec-
ular Technologies, St. Louis, MO) via chemiluminescence with
Immun-Star WesternC (Bio-Rad Hercules, CA) following the
manufacturer’s instructions.
For the kinase assay, cleared lysate was rotated with anti-c-Myc
Agarose beads (Sigma, St. Louis, MO) for 3 hrs at 4C. Beads were
washed 4 times with RIPA buffer and then twice in kinase equili-
bration buffer (20 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM
DTT). Beads were resuspended in 20 ml of kinase assay buffer
(20 mM HEPES [pH 7.5], 10 mM MgCl2, 1 mM DTT, 10 mM
MnCl2, 2 mg/ml leupeptin, 10 mM ATP, 2 mg myelin basic protein
[Active Motif, Carlsbad, CA], and 2 mCi ATP-g 32P) and incubated
for 30 min at 30C. Reactions were terminated with 53 SDS PAGE
buffer and run on a 15% SDS-PAGE gel. The dried gels were
exposed to a Phosphorimager screen overnight and scanned
with a Typhoon Phosphorimager (GE Healthcare, Piscataway,
NJ). Quantitation of scans was performed with ImageJ software.Analysis of MAK Isoforms
We used Trizol (Invitrogen) or Paxgene Blood RNA kit (Qiagen,
Venlo, the Netherlands) to isolate RNA from fresh human retina
and testis according to the manufacturer’s instructions. We used
SuperScript II reverse transcriptase (Invitrogen) or iScript cDNAThe AmericSynthesis kit (BioRad, Hercules, CA, USA) to generate cDNA per
the manufacturer’s instructions and PCR primers that span the
75 bp alternative exon to amplify MAK transcripts from retinal
and testis cDNA (Table S3).Bioinformatic Analysis of Ciliary-Gene
Regulation by CRX
A list of 200 phylogenetically conserved ciliary genes with RefSeq
identifiers was obtained from Table S8 of a recent study of the
mouse photoreceptor sensory cilium complex22 and was
compared with the genes listed in Table S1 of the present study.
All ciliary genes that had assigned CBRs in either the wild-type
or Nrl/ datasets were defined as CBR associated.Results
CRX-Based cis-Regulatory Mapping
of Retinal-Disease Genes
The majority of genes known to be involved in RD show
photoreceptor-enriched expression;9,11,14 thus we hypoth-
esized that the genome-wide pattern of binding of CRX,
a global transcriptional regulator of photoreceptor genes,
could be used to pinpoint novel genes that, whenmutated,
cause RD. We previously discovered that CBRs cluster
around known photoreceptor genes in the mouse.9 To
determine whether this is also true in humans, we used
the UCSC Genome Browser liftover tool to map 10,212
mouse CBRs onto the human genome. We found that
~80% (8,214/10,212) of mouse CBRs mapped successfully
to the human genome. We assigned CBRs to individual
genes across the human genome on the basis of proximity
and found that they tightly cluster around photoreceptor
genes (Table S1).
Next, we determined whether these assignments could
be used to identify retinal-disease genes within defined
genomic intervals. As a test case, we attempted to
rediscover Rhodopsin (RHO; MIM 180380) because muta-
tions in this gene are known to cause RP.23,24 We analyzed
a 51 gene region around RHO (including 25 on either side
of RHO; Figure 1A). The CBR assignments in the immediate
vicinity of RHO are shown in Figure 1B. The number of raw
sequence reads at a given CBR reflects the extent of CRX
binding at that CBR. Thus, by tallying the number of raw
sequence reads assigned to each of the 51 genes in this
region, we can derive a ranked list of genes that reflects
how heavily they are bound by CRX. With this approach,
RHO is ranked as the number one retinal-disease gene
candidate within this genomic region (Figure 1C).
Next, we attempted to use this approach to rediscover
the 33 additional genes known to be mutated in auto-
somal-recessive RP. As was done with RHO, we created
ranked lists of candidate genes for a 51 gene region around
each locus. We found that in 62% of cases (21/34,
including RHO), the gene known to be mutated in auto-
somal-recessive RP ranked among the top three candidates
(Figure S1A, available online). In addition, more than one-
third (12/34) of the genesmutated in RP were ranked as thean Journal of Human Genetics 89, 253–264, August 12, 2011 255
Figure 1. cis-Regulatory Mapping at the RHO Locus
(A) The genomic interval including 25 genes on either side of the human RHO locus (pink oval) spans 4.8 Mb.
(B) There are eight CBRs in the immediate vicinity of the RHO locus that were assigned to nearby genes as indicated by the arrows. The
number of raw sequence reads corresponding to each of the CBRs is shown.
(C) The 51 genes shown in (A) were ranked according to the number of raw sequence reads assigned to them. The RHO locus
(green arrow), which was assigned a total of 579 raw sequence reads, ranked number one out of all 51 genes in this interval. Only
the ten highest ranking genes are shown. Portions of the images in (A) and (B) are adapted from the UCSC Genome Browser.38number one candidate within their corresponding region.
An additional gene (DHDDS; MIM 608172) was ranked
fifth in its interval. Overall, the cis-regulatory mapping
approach successfully prioritized the gene known to be
mutated in RP in nearly two-thirds of cases.
In 12 cases, CRX-based cis-regulatory mapping failed to
rank the known gene highly. The reason for this becomes
apparent upon inspection of the expression pattern of
these genes. Half of the genes (6/12) are expressed in
retinal pigment epithelium (RPE) and not in photorecep-
tors (Figure S1B). Thus, these genes would not be predicted
to be regulatory targets of CRX in themouse. Another gene
that was not assigned any CBRs was EYS (MIM 612424). In
this case, the approach failed because the mouse genome
does not contain an ortholog of EYS, and thus no CBRs
were found in its vicinity.
This same approach can also be extended to other
categories of retinal disease. We found comparable rates
of success upon reanalyzing known loci implicated in
autosomal-dominant RP, autosomal-recessive Leber con-
genital amaurosis, and autosomal-dominant cone-rod
dystrophy (data not shown). In contrast, this approach
was less successful at predicting the genes mutated in ach-
romatopsia, which tend to be cone-specific.25 Given that
the Crx ChIP-seq dataset we used derives from wild-type
retinas, and most of the raw sequence reads therefore
derive from rods,9 this failure is understandable. To address
this issue, we performed cis-regulatory mapping by using
Crx ChIP-seq data derived from Nrl/ retinas that repre-
sent an enriched source of cones9,26–28 (Table S1). When
we applied this approach to the known achromatopsia
(ACHM) loci, we found that three of the four genes known256 The American Journal of Human Genetics 89, 253–264, August 1to be mutated in autosomal-recessive ACHM were pre-
dicted as the number one candidate within a 51 gene
interval (data not shown).
Mutations in the Ciliary Gene MAK
Cause Autosomal-Recessive RP
To determine whether CRX-based cis-regulatory mapping
could help to identify causative genes within exome data-
sets, we analyzed exome-sequence data from an individual
with RP after first excluding mutations in genes known to
be implicated in this disease. ThisTurkish individual,whose
parents were first cousins, is the only affected member of
her family (IV:1 in Figure 2A). We identified sequence
variants in the subject’s exome data and removed all
variants found in the dbSNP database (build 129), which
left a total of 38 genes with putative homozygous or
compound heterozygous mutations (Table S2). We then
ranked these 38 genes by using CRX-based cis-regulatory
mapping (Figure 2B and Table S2). The top five candidate
mutations were tested by Sanger sequencing, which
confirmed homozygous variants in SGIP1 (MIM 611540),
MAK, and FRYL in the subject. The variants identified in
USH2A (MIM 608400) and CTBP2 (MIM 602619) were not
confirmed. The exons containing the variants in SGIP1,
MAK, and FRYL were then sequenced in the subject’s
parents and siblings. The variant in SGIP1 did not segregate
with the disease and was therefore excluded from the
analysis. The variants in FRYL and MAK both segregated
with the disease phenotype. Homozygosity mapping per-
formed on the subject identified nine regions of identity
by descent totaling ~48 Mb of genomic DNA (data not
shown). FRYL and MAK fall within the first and fourth2, 2011
Figure 2. cis-Regulatory Mapping Identifies MAK as a Cause of Retinitis Pigmentosa
(A) The family tree of the Turkish subject with RP.
(B) The 38 genes with putative homozygous mutations in the exome-sequence dataset were ranked according to their number of raw
sequence reads. MAK (green arrow) ranked fourth. Only the ten highest ranking genes are shown.
(C) CBRs in the vicinity of the MAK locus.
(D) A PCR product encompassing MAK-CBR3 was cloned into a DsRed reporter vector and coelectroporated along with a ubiquitously
expressing CAG-eGFP loading control into explanted P0 mouse retinas. The retinas were grown for 8 days and then imaged in both red
and green channels in flat-mount and as cross-sections. MAK-CBR3 drives strong, photoreceptor-specific expression restricted to the
outer nuclear layer. The following abbreviations are used: ONL, outer nuclear layer; INL, inner nuclear layer; GCL, ganglion cell layer.largest identical-by-descent regions, respectively. The
amino acid change in FRYL (RefSeq NM_015030.1;
c.2668C>T [p.Pro890Ser]) is predicted tobenonpathogenic
by two prediction programs (SIFT: tolerated, score 0.28;
Polyphen2: benign, score 0.015). Given that the muta-
tion in MAK (RefSeq NM_001242957.1; c.718C>T
[p.Gln240X]) resulted in a premature stop codon predicted
to truncate more than half of the protein, we focused ourThe Americsubsequent analysis on this candidate. Both of the subject’s
parents and her four healthy siblings were all heterozygous
carriers of the mutation, which was not identified in 130
healthy Turkish control individuals (Figure 2A).
Three CBRs were identified around the MAK locus:
MAK-CBR1, which partly overlapped the first noncoding
exon of MAK, and MAK-CBR2 and 3, which are located
within the first intron (Figure 2C). We tested thean Journal of Human Genetics 89, 253–264, August 12, 2011 257
Table 1. Clinical Characteristics of Individuals with MAK Mutations
Subject
Number
Country
of Origin Gender
Age at
Diagnosis
(years)
Age
at Most
Recent
Examination
Initial
Symptom
Visual Acuity (Refraction in Diopters)
Full
Field ERG
Fundoscopic
Findings Perimetry
Additional
Findings Diagnosis
MAK
MutationRight Eye Left Eye
RP-2011 Turkey F ~20 31 night
blindness
20/25 no
refraction
20/25 no
refraction
minimal
responses
for both rods
and cones
diffuse
pigmentation
throughout
fundus
constricted
visual
fields;
25 degrees
consanguinity RP c.718C>T;
(p.Gln240*)/
c.718C>T;
(p.Gln240*)
009539 Netherlands F 37 57 night
blindness
20/125
(2.5 SE)
20/40
(1.5 SE)
no responses bone spicules
and attenuated
vessels;
Bullseye-like
maculopathy
central islands
of 10 degrees
with small
nasal patches
consanguinity;
lens opacities
RP c.388A>C
(p.Asn130His)/
c.388A>C
(p.Asn130His)
027775 Netherlands M 23a 23 visual field
defects
20/25
(2.25 SE)
20/25
(3 SE)
severely
reduced rod
responses,
mildly
reduced
cone
responses
no bone
spicules;
RPE alterations
and possibly
early stage
atrophy;
attenuated
vessels; optic
disc pallor
constricted
visual
field,
20 degrees
none RP c.37G>A
(p.Gly13Ser)/
c.37G>A
(p.Gly13Ser)
038230 Netherlands F 43b 47 night
blindness
(since
childhood);
visual field
defects at
presentation
20/20
(7 SE)
20/20
(7 SE)
signficantly
reduced rod
responses
and mildly
reduced
cone
responses
(at 43 years)
mild pallor
optic disc,
moderately
attenuated
vessels;
preserved
macular region;
RPE atrophy
and bone-spicules
in the nasal
quadrants
constricted
visual fields
with temporal
scotomas in the
midperiphery
none sectorial
RP
c.79G>C
(p.Gly27Arg)/
c.542T>C
(p.Ile181Thr)
012115 Netherlands F 51 59 night
blindness
20/32 no
refraction
20/100 no
refraction
NA attenuated
vessels;
bone spicule
pigmentation
mild
constriction
and arcuate
scotomas
subcapsular
posterior
cataract
OS>OD
RP c.79G>A
(p.Gly27Arg)/
r.0
MOL07 08-1 Israel F 32 49 night
blindness
20/32 –20/40
(2.75 SE)
20/25-20/32
(2.5 SE)
severely
reduced rod
responses,
moderately
reduced cone
responses
posterior poles
normal; mild
changes in
nasal retina
localized
visual field
loss: BE
midperipheral
temporal
scotomas
consanguinity sectorial
RP
c.497G>A
(p.Arg166His)/
c.497G>A
(p.Arg166His)
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The Americcis-regulatory activity of these three human CBRs by elec-
troporating individual CBR-reporter fusion constructs
into newborn mouse retinas. Whereas MAK-CBR1 and 2
did not drive any expression by themselves (data not
shown), MAK-CBR3 drove strong, photoreceptor-specific
expression within the retina (Figure 2D). These findings
suggest that MAK-CBR3 represents a bona fide cis-regula-
tory region for MAK and that CRX is a direct transcrip-
tional regulator of this gene. Previous studies have shown
that about half of CBRs demonstrate autonomous photore-
ceptor-specific cis-regulatory activity in this assay.9,13 In
addition, many of the nonfunctioning CBRs can act as
potent enhancers or repressors when placed next to an
adjacent CBR.9 We therefore tested MAK-CBR1 and 2 for
enhancer activity by cloning them upstream of a Rho
promoter shown previously to drive rod-specific expres-
sion.9 This assay revealed a strong enhancement of
reporter transcription relative to the Rho promoter alone,
indicating thatMAK-CBR1 and 2 do indeed possess potent
enhancer activity (data not shown).
Next, we screened for MAK mutations in additional
individuals with RP. Whole-genome SNP analysis of 334
isolated or autosomal-recessive RP subjects of Dutch,
Italian, Israeli, and Palestinian origins revealed 11 RP
probands with a large homozygous region encompassing
MAK (Table S4). Mutation analysis ofMAK revealed homo-
zygous missense mutations in three of these probands:
c.37G>A (p.Gly13Ser) in subject 027775 (II:3 in Figure S2),
c.388A>C (p.Asn130His) in subject 009539 (II:5 in
Figure S2), and c.497G>A (p.Arg166His) in subject
MOL0708-1 (II:4 in Figure S2) (Table 1). The p.Arg166His
mutation segregates with the disease in the family of
subject MOL0708-1 (which is of oriental Jewish origin):
two affected siblings are homozygous for the mutation,
whereas one unaffected sibling is heterozygous and two
unaffected siblings do not carry the mutation (Figure S2).
The p.Arg166His mutation was identified in the heterozy-
gous state in one out of 217 oriental Jewish controls. The
p.Gly13Ser and p.Asn130His mutations were not identi-
fied in 163 Dutch control individuals.
In addition, we screened 93 Dutch isolated or autosomal-
recessive RP subjects for mutations in all coding exons and
splice junctions of MAK by direct sequencing. In the
majorityof these individuals,mutations ingenespreviously
implicated in RP had already been excluded. This analysis
identified compound heterozygous missense mutations in
subject 038230 (II:3 in Figure S2): c.79G>C (p.Gly27Arg)
and c.542T>C (p.Ile181Thr) (Table 1). Segregation analysis
within this family revealed that the sister of this individual
carries both of themutations. The disease status of this indi-
vidualmust be determined through clinical tests. Heterozy-
gous changes were detected in two RP subjects: c.79G>A
(p.Gly27Arg) was detected in subject 012115 (II:1 in
Figure S2) and c.974C>T (p.Pro325Leu) in subject 050135
(data not shown). Although no second pathogenic allele
was found in individual 012115 on the genomicDNA level,
RNA analysis of peripheral blood revealed the presence ofan Journal of Human Genetics 89, 253–264, August 12, 2011 259
a hemizygous c.79G>A (p.Gly27Arg) mutation, indicating
the lack of an RNA product from the second allele. The
p.Pro325Leu variant in subject 050135 was not detected
in the subject’s affected sibling, suggesting that it is not
pathogenic, when assuming an autosomal-recessive mode
of inheritance. None of the missense variants (p.Gly27Arg,
p.Ile181Thr, and p.Pro325Leu) were detected in 163 Dutch
control individuals.
The clinical findings for individuals carrying MAK
mutations are presented in Table 1. The age at diagnosis
in three of eight subjects was in the third decade of life
and in the remaining five subjects in the fourth through
sixth decades of life. In retrospect, however, retinal
dysfunction had been present at an earlier age in at least
one subject (038230). Visual acuity was relatively
preserved in the subjects, and six of the eight subjects
displayed 20/40 or better in at least one eye. The visual
field appears to be more heavily affected: half of the
subjects experienced tunnel vision of 25 degrees or less.
Interestingly, two subjects demonstrated sectorial RP.
Consanguinity was present in at least three of the index
subjects. Overall, individuals with MAK mutations appear
to have a disease course that is somewhat less rapid and
severe than what has been observed in a number of other
genetic forms of RP.
MAK encodes a highly-conserved regulator of ciliary
length that contains a MAP kinase domain in its
N-terminal half (Figure 3A). Mutations in the MAK ortho-
logs of Chlamydomonas reinhardtii, Leishmania mexicana,
Caenorhabditis elegans, and mice result in formation of
abnormally long cilia.15–17,29 Mak mutations in mice
also cause rapid degeneration of photoreceptors.17 All
six of the putatively pathogenic mutations in MAK that
we identified fall within the conserved kinase domain
(Figure 3A). The most severe mutation (p.Gln240*) creates
a premature stop codon within the C-terminal portion of
the domain that is predicted to remove kinase subdomain
XI.30 All missense mutations (p.Gly13Ser, p.Gly27Arg,
p.N130S, p.Arg166His, and p.Ile181Thr) are predicted to
be pathogenic with various pathogenicity prediction
programs (Table S5). In addition, two missense mutations
(p.Gly13Ser and p.Asn130His) affect amino acids that are
universally conserved across all known kinases.30 These
amino acids correspond to glycine 52 and asparagine
171 in cAMP-dependent protein kinase that serves as
a paradigm for kinase structure/function relations.30–32
Glycine 52 forms part of a critical glycine-rich loop
required for binding ATP.32 Asparagine 171, in contrast,
acts as a stabilizer within the catalytic loop of the
protein.32 The other three mutations we identified
(p.Gly27Arg, p.Arg166His, and p.Ile181Thr) all affect
highly-conserved residues within the kinase domain.
These results strongly suggest that kinase activity is crit-
ical for the normal function of the MAK gene product
in photoreceptors.
In order to evaluate the effects of these mutations on
MAK kinase activity directly, we employed an in vitro260 The American Journal of Human Genetics 89, 253–264, August 1kinase assay. An expression construct was engineered
that contained the full-length wild-type human MAK
coding sequence derived from retinal cDNA. In addition,
two variant constructs were engineered that carried the
human mutations that affect universally conserved amino
acids (p.Gly13Ser and p.Asn130His). We found that the
wild-type MAK protein resulted in increased phosphoryla-
tion of myelin basic protein relative to background
(Figure 3B). In contrast, the kinase activity observed with
the two mutant forms of MAK was essentially the same
as that seen with the empty vector (Figure 3B). These
results confirm that these two disease-causing mutations
result in a loss of kinase activity in vitro.
PCR amplification of the full-length MAK coding
sequence from human retina resulted in the identifica-
tion of a photoreceptor-enriched alternative exon
(number 13) that was previously reported in mice17 (Fig-
ure 4A). This exon corresponds to a block of phylogenetic
conservation encoding 25 amino acids (Figure 4A). Given
the relatively restricted pattern of expression of MAK in
testis and retina,17 we determined the extent to which
the two transcript isoforms (with and without the alterna-
tive exon) are expressed in these two tissues in humans.
We found that the longer isoform (including the alterna-
tive exon) is the predominant species in the retina, and
there is only a barely detectable level of expression of
the shorter isoform (Figure 4B). In contrast, in testis,
the short isoform predominates, whereas the longer
form is detectable at lower levels. A similar pattern of
retinal- and testis-predominance of the long and short
isoforms, respectively, was also observed in mice (data
not shown).
CRX Is a Global Transcriptional Regulator
of Ciliary Genes in Photoreceptors
The binding of CRX around theMAK locus suggests a previ-
ously underappreciated role for CRX in regulating the
expression of cilium-related genes in photoreceptors. To
explore this idea further, we bioinformatically analyzed
a large set of ciliary genes for direct binding by CRX by
using our CRX ChIP-seq dataset. A prior analysis of the
proteome of the mouse photoreceptor sensory cilium
complex (i.e., the outer segment) revealed the presence
of more than a thousand different proteins in this struc-
ture.22 Among these were more than 200 genes encoding
phylogenetically conserved ciliary proteins. We analyzed
200 of these genes and found that ~60% (119/200) had
CBRs associated with them (data not shown). This figure
represents a marked enrichment for CRX binding around
ciliary genes compared to binding around all genes in
the genome (P ¼ 1.07 3 1024, hypergeometric dis-
tribution). CRX binding was also detected in the
proximal promoter region of RFX1 (MIM 600006), a key
transcriptional regulator of ciliary genes (data not
shown).33 Taken together, these data suggest that CRX
might directly regulate many cilium-related genes
including a critical transcriptional regulator of these genes.2, 2011
Figure 3. Analysis of Additional MAK Mutations
(A) Schematic of the MAK protein shows the location of six identified disease-associated mutations. Cross-species comparison of two
regions of MAK indicate that all the identified missense mutations affect highly-conserved residues.
(B) In vitro kinase assay showing that two mutations in MAK, p.Gly13Ser and p.Asn130His, result in a loss of kinase activity. Note that
there is a modest background level of phosphorylation of myelin basic protein (MBP) even in the empty vector control condition. The
graph at the bottom shows results for two biological replicates of the kinase assay. The amount of phospho-MBP is normalized to the
amount of kinase expressed. Error bars represent standard deviation.Discussion
This study introduces a bioinformatic strategy called
cis-regulatory mapping for prioritizing candidate genes
within lists derived from either genetic mapping or exome
sequencing of individuals with retinal degeneration. WeThe Americused this approach to identify a homozygous mutation
in MAK in a Turkish individual with RP. Further studies
revealed additional mutations in MAK in RP subjects
from several geographical regions. MAK encodes a cilium-
associated MAP kinase that is selectively expressed in
retina and testis. Two disease-causing mutations in MAKan Journal of Human Genetics 89, 253–264, August 12, 2011 261
Figure 4. The Predominant Retinal Transcript Isoform of MAK
Includes an Alternative Exon
(A) Pattern of phylogenetic conservation within the alternative
exon of MAK. The images are adapted from the UCSC Genome
Browser.38
(B) PCR results assessing the presence of the alternative exon in
cDNA derived from the human retina and testis.result in a loss of kinase activity in vitro and suggest
a critical role for kinase activity in photoreceptor survival
in humans. In addition, a retina-enriched transcript
isoform ofMAK was identified that contains an alternative
13th exon. Because all identifiedMAKmutations are shared
by both retinal- and testis-enriched isoforms, it is possible
that mutations in this gene could affect spermatogenesis.
Overall, the cis-regulatory mapping approach should be
widely applicable to the prioritization of retinal-disease
gene candidates, and the generation of ChIP-seq datasets
for other retinal disease relevant cell types such as RPE
should allow the further extension of this strategy.
Unlike other approaches for candidate-gene prioritiza-
tion, cis-regulatory mapping does not depend on knowl-
edge of gene expression pattern (i.e., whether a candidate
gene is enriched in retina) or the extent of gene annota-
tion. In individuals with dominant retinal disease, the
list of candidate mutations in exome data is longer
compared to that in recessive disease because a single
heterozygous mutation is sufficient to cause disease.
CRX-based cis-regulatory mapping should therefore be262 The American Journal of Human Genetics 89, 253–264, August 1particularly useful in such individuals. Overall, CRX-based
cis-regulatory mapping appears to be a sensitive and
versatile tool for prioritizing retinal-disease genes in
many rod- and cone-based diseases.
The ability of CRX ChIP-seq data to facilitate candidate-
gene prioritization in retinal disease was recently demon-
strated in another study that pinpointed mutations in
FAM161A (MIM 613596) as a cause of RP.34 In addition,
preliminary analyses suggest that CRX-based cis-regulatory
mapping is effective at prioritizing retinal-disease candi-
date genes in mice (data not shown). In order to facilitate
the application of this approach tomousemodels of retinal
disease, we have included cis-regulatory mapping datasets
for mice in Table S1.
The cis-regulatory mapping approach introduced here
should, in principle, be applicable to disease gene priori-
tization in any differentiated cell type. Crx is a terminal
selector gene that coordinately regulates a host of different
genes required for the differentiation of photorecep-
tors.10,11,13,35 Such key regulators are known to be present
in many cell types. If the identity of a key regulatory
transcription factor is known, the creation of a cis-regula-
tory map with ChIP-seq should therefore permit the
application of this strategy to other families of diseases
affecting specific cell types. For example, CRX-based
cis-regulatory mapping failed to identify mutations in
genes expressed in RPE, and this suggests that additional
ChIP-seq datasets for regulators of RPE gene expression
such as OTX2 or MITF might facilitate the identification of
such disease genes. Similar considerations apply to a range
of other disease-relevant cell types throughout the body.
Despite the fact that the CRX ChIP-seq data used in this
study were generated in mice, they proved effective at
pinpointing photoreceptor genes in humans. This finding
suggests that the high degree of phylogenetic conservation
observed atmanyCRXChIP-seq peaks is indicative of func-
tional conservation at the level of transcriptional control of
gene expression. This result stands in contrast to a recent
report that found that there is relatively poor cross-species
correlation between ChIP-seq peaks for certain liver tran-
scription factors.36 It is therefore possible that individual
transcription factors differ with respect to the evolutionary
rate of turnover of their target binding sites. In the case of
CRX, this rate appears to be relatively slow.
Mak knockout mice displayed normal retinogenesis,
with progressive retinal degeneration of both rods and
cones beginning around 1 month of age.17 This time
course of disease progression appears to be somewhat
accelerated relative to the human subjects who had MAK
mutations and whose symptoms first developed relatively
late in life. Whereas the visual field defects were a promi-
nent feature in the human subjects, loss of visual acuity
was generally mild. Sectorial RP was present in two of the
subjects with MAK mutations and represents a relatively
uncommon subtype of RP in which a specific region of
the retina appears to be more heavily or even uniquely
affected. Determining the extent of this phenotype will2, 2011
require the identification of a larger number of individuals
with MAK mutations.
All of the MAKmutations identified in the present study
fall within exons shared by both retinal- and testis-
enriched transcript isoforms, raising the possibility that
these mutations could have an effect on spermatogenesis.
However, there were no reports of infertility in the two
male subjects we identified. This finding is consistent
with the phenotype of the Mak knockout mouse, which
is fertile and has only mild defects in sperm motility.37
Nevertheless, given the expression pattern of MAK,
analysis of sperm function in subjects carrying mutations
in this gene might be warranted.
In conclusion, this study introduces a bioinformatic
strategy for prioritizing retinal-disease gene candidates
based on the genome-wide pattern of binding of the photo-
receptor transcription factor CRX. This approach success-
fully identified RP-causing mutations in a ciliary gene,
MAK, and should be widely applicable to retinal-disease
gene candidate prioritization in a range of retinal diseases.Supplemental Data
Supplemental Data include two figures and five tables and can be
found with this article online at http://www.cell.com/AJHG/.Acknowledgements
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